Pain Management during Rehabilitation after Distal Radius Fracture Stabilized with Volar Locking Plate: A Prospective Cohort Study
Table 2
VAS scores (mm) measured every week during rehabilitation program.
Celecoxib (n=149)
Transdermal buprenorphine (n=89)
Codeine/ ibuprofen (n=77)
P value
Week 1
VAS score (rest)
27 (8)
26 (8)
28 (8)
0.35
VAS score (daily activity)
31 (10)
32 (10)
33 (11)
0.66
VAS score (rehabilitative exercise)
67 (22)#
45 (14)
42 (12)
< 0.01
Completing the rehabilitation program
80 (54)
68 (76)
57 (74)
< 0.01
Week 2
VAS score (rest)
24 (7)
22 (7)
23 (6)
0.29
VAS score (daily activity)
26 (9)
25 (8)
24 (10)
0.34
VAS score (rehabilitative exercise)
41 (17)#
30 (11)
32 (10)
< 0.01
Completing the rehabilitation program
110 (74)
76 (85)
66 (86)
0.03
Week 3
VAS score (rest)
19 (6)
18 (5)
18 (6)
0.11
VAS score (daily activity)
22 (7)
20 (7)
21 (7)
0.10
VAS score (rehabilitative exercise)
26 (8)
24 (8)
24 (8)
0.16
Completing the rehabilitation program
135 (91)
80 (90)
68 (88)
0.86
Week 4
VAS score (rest)
15 (5)
16 (5)
16 (5)
0.37
VAS score (daily activity)
16 (6)
15 (5)
17 (8)
0.39
VAS score (rehabilitative exercise)
17 (8)
19 (9)
18 (6)
0.20
Completing the rehabilitation program
141 (95)
82 (92)
72 (94)
0.75
Week 5
VAS score (rest)
12 (4)
12 (4)
12 (4)
0.82
VAS score (daily activity)
12 (5)
13 (6)
11 (5)
0.39
VAS score (rehabilitative exercise)
14 (5)
14 (5)
14 (7)
0.85
Completing the rehabilitation program
144 (97)
86 (97)
73 (95)
0.77
Week 6
VAS score (rest)
6 (4)
7 (4)
7 (4)
0.11
VAS score (daily activity)
8 (4)
8 (4)
8 (4)
0.35
VAS score (rehabilitative exercise)
8 (3)
7 (3)
8 (3)
0.04
Completing the rehabilitation program
142 (95)
84 (94)
74 (96)
0.87
Pain medication was given only in Week 1 and 2. Figures are Mean (SD) for VAS score and otherwise number (percentage). P < 0.05 versus celecoxib group; # P < 0.05 versus transdermal buprenorphine group. P value was calculated using Student’s t test.
